Medicaid investigation
Executive Summary
AstraZeneca says it has not received a subpoena related to Boston U.S. attorney's investigation of repackaging as a potential avenue to avoid Medicaid rebate payments. Prilosec is one of the products repackaged by Kaiser, which has been subpoenaed (1"The Pink Sheet" Nov. 6, p. 3)
You may also be interested in...
SmithKline, Bayer Subpoenaed In Medicaid Repackaging Investigation
A Boston grand jury is conducting an investigation of Kaiser's prescription drug repackaging operations as a potential avenue around the Medicaid "best price" rebate system.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials